Selected research
Industry Research
Transdermal Skin Patch Industry Research Report 2026
Market perspective
The global Transdermal Skin Patch market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Transdermal Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Transdermal Skin Patch is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Transdermal Skin Patch is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Transdermal Skin Patch include Actavis, Changzhou Siyao, Henan Lingrui Pharmaceutical, Hisamitsu Pharmaceutical, Luye Pharma Group Ltd., Mundipharma, Purdue Pharma L.P., Rfl Pharmaceutical and Teikoku Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Transdermal Skin Patch market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transdermal Skin Patch Market by Company
Actavis
Changzhou Siyao
Henan Lingrui Pharmaceutical
Hisamitsu Pharmaceutical
Luye Pharma Group Ltd.
Mundipharma
Purdue Pharma L.P.
Rfl Pharmaceutical
Teikoku Pharma
Mylan
Novartis
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Transdermal Skin Patch Segment by Type
Buprenorphine Transdermal Skin Patch
Fentanyl Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Transdermal Skin Patch Segment by Application
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
Transdermal Skin Patch Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Transdermal Skin Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Transdermal Skin Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Buprenorphine Transdermal Skin Patch
- Fentanyl Transdermal Skin Patch
- Clonidine Transdermal Skin Patch
- Nicotine Transdermal Skin Patch
Applications
- Relieve Severe Pain
- Stop Smoking Cigarettes
- Treat an Overactive Bladder
- Others
Companies covered
- Actavis
- Changzhou Siyao
- Henan Lingrui Pharmaceutical
- Hisamitsu Pharmaceutical
- Luye Pharma Group Ltd.
- Mundipharma
- Purdue Pharma L.P.
- Rfl Pharmaceutical
- Teikoku Pharma
- Mylan
- Novartis
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Transdermal Skin Patch Market Size (2021-2032)
- 2.2.2 Global Transdermal Skin Patch Sales (2021-2032)
- 2.2.3 Global Transdermal Skin Patch Market Average Price (2021-2032)
- 2.3 Transdermal Skin Patch by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Buprenorphine Transdermal Skin Patch
- 2.3.3 Fentanyl Transdermal Skin Patch
- 2.3.4 Clonidine Transdermal Skin Patch
- 2.3.5 Nicotine Transdermal Skin Patch
- 2.4 Transdermal Skin Patch by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Relieve Severe Pain
- 2.4.3 Stop Smoking Cigarettes
- 2.4.4 Treat an Overactive Bladder
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Transdermal Skin Patch Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Transdermal Skin Patch Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Transdermal Skin Patch Revenue of Manufacturers (2021-2026)
- 3.4 Global Transdermal Skin Patch Average Price by Manufacturers (2021-2026)
- 3.5 Global Transdermal Skin Patch Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Transdermal Skin Patch, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Transdermal Skin Patch, Product Type & Application
- 3.8 Global Manufacturers of Transdermal Skin Patch, Established Date
- 3.9 Global Transdermal Skin Patch Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Actavis
- 4.1.1 Actavis Company Information
- 4.1.2 Actavis Business Overview
- 4.1.3 Actavis Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Actavis Transdermal Skin Patch Product Portfolio
- 4.1.5 Actavis Recent Developments
- 4.2 Changzhou Siyao
- 4.2.1 Changzhou Siyao Company Information
- 4.2.2 Changzhou Siyao Business Overview
- 4.2.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Changzhou Siyao Transdermal Skin Patch Product Portfolio
- 4.2.5 Changzhou Siyao Recent Developments
- 4.3 Henan Lingrui Pharmaceutical
- 4.3.1 Henan Lingrui Pharmaceutical Company Information
- 4.3.2 Henan Lingrui Pharmaceutical Business Overview
- 4.3.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio
- 4.3.5 Henan Lingrui Pharmaceutical Recent Developments
- 4.4 Hisamitsu Pharmaceutical
- 4.4.1 Hisamitsu Pharmaceutical Company Information
- 4.4.2 Hisamitsu Pharmaceutical Business Overview
- 4.4.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio
- 4.4.5 Hisamitsu Pharmaceutical Recent Developments
- 4.5 Luye Pharma Group Ltd.
- 4.5.1 Luye Pharma Group Ltd. Company Information
- 4.5.2 Luye Pharma Group Ltd. Business Overview
- 4.5.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio
- 4.5.5 Luye Pharma Group Ltd. Recent Developments
- 4.6 Mundipharma
- 4.6.1 Mundipharma Company Information
- 4.6.2 Mundipharma Business Overview
- 4.6.3 Mundipharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mundipharma Transdermal Skin Patch Product Portfolio
- 4.6.5 Mundipharma Recent Developments
- 4.7 Purdue Pharma L.P.
- 4.7.1 Purdue Pharma L.P. Company Information
- 4.7.2 Purdue Pharma L.P. Business Overview
- 4.7.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio
- 4.7.5 Purdue Pharma L.P. Recent Developments
- 4.8 Rfl Pharmaceutical
- 4.8.1 Rfl Pharmaceutical Company Information
- 4.8.2 Rfl Pharmaceutical Business Overview
- 4.8.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio
- 4.8.5 Rfl Pharmaceutical Recent Developments
- 4.9 Teikoku Pharma
- 4.9.1 Teikoku Pharma Company Information
- 4.9.2 Teikoku Pharma Business Overview
- 4.9.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teikoku Pharma Transdermal Skin Patch Product Portfolio
- 4.9.5 Teikoku Pharma Recent Developments
- 4.10 Mylan
- 4.10.1 Mylan Company Information
- 4.10.2 Mylan Business Overview
- 4.10.3 Mylan Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mylan Transdermal Skin Patch Product Portfolio
- 4.10.5 Mylan Recent Developments
- 4.11 Novartis
- 4.11.1 Novartis Company Information
- 4.11.2 Novartis Business Overview
- 4.11.3 Novartis Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Novartis Transdermal Skin Patch Product Portfolio
- 4.11.5 Novartis Recent Developments
- 4.12 Johnson & Johnson
- 4.12.1 Johnson & Johnson Company Information
- 4.12.2 Johnson & Johnson Business Overview
- 4.12.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Johnson & Johnson Transdermal Skin Patch Product Portfolio
- 4.12.5 Johnson & Johnson Recent Developments
- 4.13 Teva Pharmaceutical Industries Ltd.
- 4.13.1 Teva Pharmaceutical Industries Ltd. Company Information
- 4.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 4.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio
- 4.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
5 Global Transdermal Skin Patch Market Scenario by Region
- 5.1 Global Transdermal Skin Patch Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Transdermal Skin Patch Sales by Region: 2021-2032
- 5.2.1 Global Transdermal Skin Patch Sales by Region: 2021-2026
- 5.2.2 Global Transdermal Skin Patch Sales by Region: 2027-2032
- 5.3 Global Transdermal Skin Patch Revenue by Region: 2021-2032
- 5.3.1 Global Transdermal Skin Patch Revenue by Region: 2021-2026
- 5.3.2 Global Transdermal Skin Patch Revenue by Region: 2027-2032
- 5.4 North America Transdermal Skin Patch Market Facts & Figures by Country
- 5.4.1 North America Transdermal Skin Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Transdermal Skin Patch Sales by Country (2021-2032)
- 5.4.3 North America Transdermal Skin Patch Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Transdermal Skin Patch Market Facts & Figures by Country
- 5.5.1 Europe Transdermal Skin Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Transdermal Skin Patch Sales by Country (2021-2032)
- 5.5.3 Europe Transdermal Skin Patch Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Country
- 5.6.1 Asia Pacific Transdermal Skin Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Transdermal Skin Patch Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Transdermal Skin Patch Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Transdermal Skin Patch Market Facts & Figures by Country
- 5.7.1 South America Transdermal Skin Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Transdermal Skin Patch Sales by Country (2021-2032)
- 5.7.3 South America Transdermal Skin Patch Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Transdermal Skin Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Transdermal Skin Patch Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Transdermal Skin Patch Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Transdermal Skin Patch Sales by Type (2021-2032)
- 6.1.1 Global Transdermal Skin Patch Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Transdermal Skin Patch Sales Market Share by Type (2021-2032)
- 6.2 Global Transdermal Skin Patch Revenue by Type (2021-2032)
- 6.2.1 Global Transdermal Skin Patch Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Transdermal Skin Patch Revenue Market Share by Type (2021-2032)
- 6.3 Global Transdermal Skin Patch Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Transdermal Skin Patch Sales by Application (2021-2032)
- 7.1.1 Global Transdermal Skin Patch Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Transdermal Skin Patch Sales Market Share by Application (2021-2032)
- 7.2 Global Transdermal Skin Patch Revenue by Application (2021-2032)
- 7.2.1 Global Transdermal Skin Patch Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Transdermal Skin Patch Revenue Market Share by Application (2021-2032)
- 7.3 Global Transdermal Skin Patch Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Transdermal Skin Patch Value Chain Analysis
- 8.1.1 Transdermal Skin Patch Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Transdermal Skin Patch Production Mode & Process
- 8.2 Transdermal Skin Patch Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Transdermal Skin Patch Distributors
- 8.2.3 Transdermal Skin Patch Customers
9 Global Transdermal Skin Patch Analyzing Market Dynamics
- 9.1 Transdermal Skin Patch Industry Trends
- 9.2 Transdermal Skin Patch Industry Drivers
- 9.3 Transdermal Skin Patch Industry Opportunities and Challenges
- 9.4 Transdermal Skin Patch Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst